Mercury 4.0 Phantom

Gammex, a Sun Nuclear Corporation company © 2018

Timothy Szczykutowicz, Ph.D., DABR, from the University of Wisconsin-Madison, recently explored use of the Mercury 4.0 Phantom to address common clinical questions and optimize CT dose management across a wide range of patient sizes. 

Complete the short form below to download his in-depth whitepaper.

Mercuy 4.0 Phantom

Advanced CT
Performance Assessment